Development of a novel immunoassay for the measurement of active plasmin in patients with IPF Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017
Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020
Development of the first protease multiplex immunoassay for active neutrophilic serine protease biomarkers Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
An innovative high sensitivity tool for active neutrophil elastase quantification Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
New enzyme linked immunosorbent assay using recombinant antigens from Saccharopolyspora rectivirgula for farmer‘s lung disease serodiagnosis Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Development of a new sensitive ELISA for the determination in serum of uteroglobin-related protein 1 (UGRP-1), a new potential lung biomarker Source: Annual Congress 2010 - Innovations in the assessment of airway diseases Year: 2010
Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology Year: 2010
Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells Source: Eur Respir J, 59 (1) 2100285; 10.1183/13993003.00285-2021 Year: 2022
Clinical evaluation of anti-glycopeptidelipid core immunoglobulin A antibody assay for serodiagnosis of pulmonary Mycobacterium avium-intracellulare complex (MAC) disease Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005
Evaluation of novel sputum processing methods and sensitive detection techniques in allergic asthmatics Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009
Investigating optimal sputum processing methods for active neutrophil elastase quantification Source: International Congress 2017 – Techniques in biomarker selection Year: 2017
Usefulness of whole blood interferon-γ assay and interferon-γ enzyme-linked immunospot assay for the diagnosis of active tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006
A comparison between UniCAP® and ADVIA Centaur® for specific IgE detection in patients with asthma Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008
A new investigational use only automated immunoassay for periostin Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Mast cell tryptase concentration measured with B12 antibody-based immunoassay in bronchoalveolar lavage fluid from patients with interstitial lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 10s Year: 2004
Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD Source: Eur Respir J, 55 (5) 1902412; 10.1183/13993003.02412-2019 Year: 2020
Validation of a sensitive, specific and quantitative flow cytometry assay for the measurement of TRPA1 protein expression in primary human lung cells and leukocytes Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019
Validation of TNF-α determinations by homogeneous time-resolved fluorescence A comparison between HTRF® and ELISA in human whole blood assays Source: Eur Respir J 2003; 22: Suppl. 45, 228s Year: 2003